{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:04:26Z","timestamp":1793426666458,"version":"4.5.0"},"reference-count":186,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100023296","name":"Alleanza Contro il Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023296","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacc.2025.09.003","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:39:07Z","timestamp":1767901147000},"page":"856-890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["2026 ACC\/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease"],"prefix":"10.1016","volume":"88","author":[{"given":"Philip P.","family":"Goodney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsie G.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Bruckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olamide","family":"Alabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Elissa","family":"Altin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Diekemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie D.","family":"Gerhard-Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily E.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria T.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parag J.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Rodriguez-Miguelez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Rymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry J.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dyane E.","family":"Tower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane J.","family":"Treat-Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2025.09.003_bib1","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.jacc.2024.02.013","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Gornik","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib2","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.jacc.2010.09.009","article-title":"ACCF\/AHA new insights into the methodology of performance measurement: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Performance Measures","volume":"56","author":"Spertus","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jacc.2005.03.011","article-title":"American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care","volume":"45","author":"Spertus","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib4","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.jacc.2010.08.606","article-title":"ACCF\/AHA\/ACR\/SCAI\/SIR\/SVM\/SVN\/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Performance Measures","volume":"56","author":"Olin","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib5","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines","volume":"63","author":"Anderson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1161\/CIRCOUTCOMES.111.962233","article-title":"Variation in the use of lower extremity vascular procedures for critical limb ischemia","volume":"5","author":"Goodney","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2025.09.003_bib7","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jvs.2012.11.068","article-title":"Regional intensity of vascular care and lower extremity amputation rates","volume":"57","author":"Goodney","year":"2013","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jvs.2022.10.025","article-title":"Early peripheral vascular interventions for claudication are associated with higher rates of late interventions and progression to chronic limb threatening ischemia","volume":"77","author":"Sorber","year":"2023","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib9","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.jacc.2019.10.001","article-title":"2019 AHA\/ACC clinical performance and quality measures for adults with high blood pressure: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"74","author":"Casey","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib10","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/intqhc\/10.3.247","article-title":"Eliciting expert opinion using the Delphi technique: identifying performance indicators for cardiovascular disease","volume":"10","author":"Normand","year":"1998","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.jacc.2025.09.003_bib12","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.jacc.2018.01.004","article-title":"2018 ACC\/AHA clinical performance and quality measures for cardiac rehabilitation: a report of the American College of Cardiology\/American Heart Association Task Force on Performance Measures","volume":"71","author":"Thomas","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.avsg.2023.11.057","article-title":"Leveraging artificial intelligence to optimize the care of peripheral artery disease patients","volume":"107","author":"Song","year":"2024","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192215231","article-title":"Smart wearable systems for the remote monitoring of selected vascular disorders of the lower extremity: a systematic review","volume":"19","author":"Souza","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jacc.2025.09.003_bib15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12911-022-01945-z","article-title":"Mobile health platform based on user-centered design to promote exercise for patients with peripheral artery disease","volume":"22","author":"Kim","year":"2022","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.jacc.2025.09.003_bib16","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib18","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/HJH.0b013e3283471151","article-title":"Effect of nebivolol vs. hydrochlorothiazide on the walking capacity in hypertensive patients with intermittent claudication","volume":"29","author":"Diehm","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.jacc.2025.09.003_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/HYPERTENSIONAHA.110.169169","article-title":"\u03b2-blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial","volume":"58","author":"Espinola-Klein","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.09.003_bib20","article-title":"Beta blockers for peripheral arterial disease","volume":"2013","author":"Paravastu","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.09.003_bib21","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s11606-014-2947-1","article-title":"Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT","volume":"29","author":"Piller","year":"2014","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib22","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/HYPERTENSIONAHA.109.142240","article-title":"Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR\/Trandolapril STudy","volume":"55","author":"Bavry","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2025.09.003_bib24","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1161\/CIRCULATIONAHA.118.033348","article-title":"Association of blood pressure measurements with peripheral artery disease events","volume":"138","author":"Itoga","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.CIR.0000049640.46039.52","article-title":"Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes","volume":"107","author":"Mehler","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3317\/jraas.2000.002","article-title":"The HOPE Study (Heart Outcomes Prevention Evaluation)","volume":"1","author":"Sleight","year":"2000","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.jacc.2025.09.003_bib27","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1358863X15574321","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia","volume":"20","author":"Armstrong","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib29","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa2004967","article-title":"Cardiovascular outcomes with ertugliflozin in type 2 diabetes","volume":"383","author":"Cannon","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib30","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1056\/NEJMc1615712","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"376","author":"Cosmi","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.09.003_bib32","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib34","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib35","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib36","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib37","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/dom.14700","article-title":"Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease","volume":"24","author":"Verma","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jacc.2025.09.003_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib39","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib40","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234065","article-title":"Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: a systematic review and meta-analysis","volume":"15","author":"Heyward","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2025.09.003_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jvs.2017.06.101","article-title":"High hemoglobin A(1c) associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization","volume":"67","author":"Arya","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107638","article-title":"Glycemic control and diabetic foot ulcer outcomes: a systematic review and meta-analysis of observational studies","volume":"34","author":"Lane","year":"2020","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jacc.2025.09.003_bib45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/1358863X14538330","article-title":"Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty","volume":"19","author":"Singh","year":"2014","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib46","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.2337\/dc10-0939","article-title":"The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia","volume":"33","author":"Takahara","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2025.09.003_bib47","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib48","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib49","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial","volume":"71","author":"Anand","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.09.003_bib51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa065959","article-title":"Warfarin Antiplatelet Vascular Evaluation Trial Investigators. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease","volume":"357","author":"Anand","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mva.2002.121847","article-title":"Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study","volume":"35","author":"Johnson","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib53","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib54","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib55","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1055\/s-0040-1709711","article-title":"Statins and major adverse limb events in patients with peripheral artery disease: a systematic review and meta-analysis","volume":"120","author":"Pastori","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2025.09.003_bib56","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.117.032361","article-title":"Association of statin dose with amputation and survival in patients with peripheral artery disease","volume":"137","author":"Arya","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jacc.2020.05.048","article-title":"Atherosclerotic risk and statin use among patients with peripheral artery disease","volume":"76","author":"Colantonio","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib58","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib59","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jacc.2019.03.013","article-title":"Alirocumab in patients with polyvascular disease and recent acute coronary syndrome: ODYSSEY OUTCOMES trial","volume":"74","author":"Jukema","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib60","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIRCULATIONAHA.120.046524","article-title":"Peripheral artery disease and venous thromboembolic events after acute coronary syndrome: role of lipoprotein(a) and modification by alirocumab: prespecified analysis of the ODYSSEY OUTCOMES randomized clinical trial","volume":"141","author":"Schwartz","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib61","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.09.003_bib62","series-title":"Smoking Cessation: A Report of the Surgeon General","year":"2020"},{"key":"10.1016\/j.jacc.2025.09.003_bib63","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.jacc.2018.10.027","article-title":"2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents","volume":"72","author":"Barua","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2020.25019","article-title":"Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force recommendation statement","volume":"325","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.09.003_bib65","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIR.0000000000001160","article-title":"Cardiopulmonary impact of electronic cigarettes and vaping products: a scientific statement from the American Heart Association","volume":"148","author":"Rose","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib66","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1016\/j.jacc.2013.11.003","article-title":"2013 AHA\/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Eckel","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib67","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7326\/M15-0171","article-title":"Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force","volume":"163","author":"Patnode","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib68","first-page":"CD000165","article-title":"Physician advice for smoking cessation","volume":"2013","author":"Stead","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.09.003_bib69","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2010.07.031","article-title":"Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial","volume":"56","author":"Hennrikus","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1161\/CIRCULATIONAHA.113.003961","article-title":"Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis","volume":"129","author":"Mills","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2856","article-title":"Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis","volume":"344","author":"Prochaska","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.09.003_bib72","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","article-title":"Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial","volume":"121","author":"Rigotti","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib73","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.2014.9237","article-title":"Sustained care intervention and postdischarge smoking cessation among hospitalized adults: a randomized clinical trial","volume":"312","author":"Rigotti","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.09.003_bib74","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0195-668X(03)00003-4","article-title":"Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study","volume":"24","author":"Tonstad","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2025.09.003_bib75","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12889-018-5227-x","article-title":"Secondhand smoke exposure and risk of incident peripheral arterial disease and mortality: a Scotland-wide retrospective cohort study of 4045 non-smokers with cotinine measurement","volume":"18","author":"Lu","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jacc.2025.09.003_bib76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijcard.2015.07.011","article-title":"Risk of all-cause mortality and cardiovascular disease associated with secondhand smoke exposure: a systematic review and meta-analysis","volume":"199","author":"Lv","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1551","article-title":"Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium","volume":"350","author":"Mons","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2025.09.003_bib78","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2017.09.024","article-title":"Environmental tobacco smoke and peripheral arterial disease: a review","volume":"266","author":"Ngu","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2025.09.003_bib79","article-title":"Endovascular revascularisation versus conservative management for intermittent claudication","volume":"3","author":"Fakhry","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.09.003_bib80","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/CIRCULATIONAHA.111.075770","article-title":"Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study","volume":"125","author":"Murphy","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib81","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2014.12.043","article-title":"Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study","volume":"65","author":"Murphy","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib82","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.avsg.2009.07.005","article-title":"Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication","volume":"24","author":"Mazari","year":"2010","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib83","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/bjs.11101","article-title":"Meta-analysis of clinical trials examining the benefit of structured home exercise in patients with peripheral artery disease","volume":"106","author":"Golledge","year":"2019","journal-title":"Br J Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib84","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2021.2536","article-title":"Effect of low-intensity vs high-intensity home-based walking exercise on walk distance in patients with peripheral artery disease: the LITE randomized clinical trial","volume":"325","author":"McDermott","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.09.003_bib85","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.2022.3391","article-title":"Effect of a home-based, walking exercise behavior change intervention vs usual care on walking in adults with peripheral artery disease: the MOSAIC randomized clinical trial","volume":"327","author":"Bearne","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.09.003_bib86","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1358863X14559092","article-title":"Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis","volume":"20","author":"Parmenter","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib87","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40279-014-0261-z","article-title":"Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis","volume":"45","author":"Parmenter","year":"2015","journal-title":"Sports Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib88","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/bjs.9207","article-title":"Long-term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial","volume":"100","author":"Fakhry","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib89","first-page":"CD005263","article-title":"Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication","volume":"4","author":"Hageman","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.09.003_bib90","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.CIR.81.2.602","article-title":"Benefit of exercise conditioning for patients with peripheral arterial disease","volume":"81","author":"Hiatt","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib91","first-page":"CD000990","article-title":"Exercise for intermittent claudication","volume":"12","author":"Lane","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.09.003_bib92","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1001\/jama.2017.17437","article-title":"Effect of granulocyte-macrophage colony-stimulating factor with or without supervised exercise on walking performance in patients with peripheral artery disease: the PROPEL randomized clinical trial","volume":"318","author":"McDermott","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.09.003_bib93","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00508-014-0548-y","article-title":"Evaluation of 6- and 12-month supervised exercise training on strength and endurance parameters in patients with peripheral arterial disease","volume":"126","author":"Pilz","year":"2014","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.jacc.2025.09.003_bib94","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/1358863X9700200313","article-title":"Exercise in the treatment of claudication: assessment and treatment of functional impairment","volume":"2","author":"Regensteiner","year":"1997","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib95","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0741-5214(05)80040-0","article-title":"Exercise training improves functional status in patients with peripheral arterial disease","volume":"23","author":"Regensteiner","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib96","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMra021135","article-title":"Exercise training for claudication","volume":"347","author":"Stewart","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib97","doi-asserted-by":"crossref","first-page":"e700","DOI":"10.1161\/CIR.0000000000000623","article-title":"Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association","volume":"139","author":"Treat-Jacobson","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib98","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.amjcard.2018.05.018","article-title":"Effects of a 12-week mHealth program on functional capacity and physical activity in patients with peripheral artery disease","volume":"122","author":"Duscha","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib99","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001107","article-title":"Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial","volume":"3","author":"Gardner","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.09.003_bib100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/CIRCULATIONAHA.110.963066","article-title":"Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial","volume":"123","author":"Gardner","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib101","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1089\/jwh.2018.7113","article-title":"Gender differences in outcomes following a pain-free, home-based exercise program for claudication","volume":"28","author":"Manfredini","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jacc.2025.09.003_bib102","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/1358863X15572725","article-title":"Community-based walking exercise for peripheral artery disease: an exploratory pilot study","volume":"20","author":"Mays","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib103","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000711","article-title":"Home-based walking exercise in peripheral artery disease: 12-month follow-up of the GOALS randomized trial","volume":"3","author":"McDermott","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.09.003_bib104","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2013.7231","article-title":"Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial","volume":"310","author":"McDermott","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.09.003_bib105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jacbts.2020.08.012","article-title":"Exercise training and revascularization in the management of symptomatic peripheral artery disease","volume":"6","author":"Biswas","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacc.2025.09.003_bib106","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/pri.1608","article-title":"Effects of 12 weeks of supervised exercise after endovascular treatment: a randomized clinical trial","volume":"20","author":"Bo","year":"2015","journal-title":"Physiother Res Int"},{"key":"10.1016\/j.jacc.2025.09.003_bib107","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejim.2021.06.029","article-title":"Comparison of supervised exercise therapy with or without revascularization for the management of intermittent claudication: SET in PAD","volume":"92","author":"Doshi","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib108","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.2015.14851","article-title":"Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial","volume":"314","author":"Fakhry","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.09.003_bib109","first-page":"150","article-title":"Combination of endovascular revascularization and supervised exercise therapy for intermittent claudication: a systematic review and meta-analysis","volume":"59","author":"Klaphake","year":"2018","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.jacc.2025.09.003_bib110","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jvir.2011.02.017","article-title":"Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a randomized clinical trial","volume":"22","author":"Kruidenier","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib111","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/bjs.10324","article-title":"Long-term outcomes of a randomized clinical trial of supervised exercise, percutaneous transluminal angioplasty or combined treatment for patients with intermittent claudication due to femoropopliteal disease","volume":"104","author":"Mazari","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib112","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s40279-016-0635-5","article-title":"Combined lower limb revascularisation and supervised exercise training for patients with peripheral arterial disease: a systematic review of randomised controlled trials","volume":"47","author":"Meneses","year":"2017","journal-title":"Sports Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib113","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jcin.2017.01.027","article-title":"Comparative efficacy of endovascular revascularization versus supervised exercise training in patients with intermittent claudication: meta-analysis of randomized controlled trials","volume":"10","author":"Pandey","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.09.003_bib114","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jcin.2019.02.018","article-title":"Supervised exercise therapy and revascularization for intermittent claudication: network meta-analysis of randomized controlled trials","volume":"12","author":"Saratzis","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2025.09.003_bib115","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3109\/09638288.2015.1077398","article-title":"Nordic pole walking improves walking capacity in patients with intermittent claudication: a randomized controlled trial","volume":"38","author":"Buli\u0144ska","year":"2016","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.jacc.2025.09.003_bib116","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/1708538115592800","article-title":"Pain-free treadmill exercise for patients with intermittent claudication: are there gender differences?","volume":"24","author":"Dipnarine","year":"2016","journal-title":"Vascular"},{"key":"10.1016\/j.jacc.2025.09.003_bib117","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ijcard.2012.10.003","article-title":"Comparison of two treadmill training programs on walking ability and endothelial function in intermittent claudication","volume":"168","author":"Mika","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib118","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bjsports-2018-100205","article-title":"Resistance training as a treatment for older persons with peripheral artery disease: a systematic review and meta-analysis","volume":"54","author":"Parmenter","year":"2020","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib119","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jvs.2010.10.125","article-title":"Upper- versus lower-limb aerobic exercise training on health-related quality of life in patients with symptomatic peripheral arterial disease","volume":"53","author":"Saxton","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1177\/1358863X08101858","article-title":"Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication","volume":"14","author":"Treat-Jacobson","year":"2009","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib121","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jvs.2005.08.021","article-title":"Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial","volume":"42","author":"Zwierska","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib122","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.CIR.0000114519.75433.DD","article-title":"High prevalence of peripheral arterial disease in persons with renal insufficiency: results from the National Health and Nutrition Examination Survey 1999-2000","volume":"109","author":"O'Hare","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib123","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib124","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13047-019-0315-4","article-title":"Challenges of foot self-care in older people: a qualitative focus-group study","volume":"12","author":"Miikkola","year":"2019","journal-title":"J Foot Ankle Res"},{"key":"10.1016\/j.jacc.2025.09.003_bib125","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.09.003_bib126","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/CIRCRESAHA.114.303517","article-title":"Lower extremity manifestations of peripheral artery disease: the pathophysiologic and functional implications of leg ischemia","volume":"116","author":"McDermott","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2025.09.003_bib127","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.286.13.1599","article-title":"Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment","volume":"286","author":"McDermott","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.09.003_bib128","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archinte.159.4.387","article-title":"Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease","volume":"159","author":"McDermott","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib129","first-page":"e346","article-title":"The accuracy of the physical examination for the detection of lower extremity peripheral arterial disease","volume":"26","author":"Armstrong","year":"2010","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib130","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jvs.2007.08.022","article-title":"Accuracy of the screening physical examination to identify subclinical atherosclerosis and peripheral arterial disease in asymptomatic subjects","volume":"46","author":"Cournot","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1358863X9600100112","article-title":"The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing","volume":"1","author":"Criqui","year":"1996","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib132","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jama.295.5.536","article-title":"Does the clinical examination predict lower extremity peripheral arterial disease?","volume":"295","author":"Khan","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2025.09.003_bib133","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jvs.2015.11.044","article-title":"Pulse palpation is an effective method for population-based screening to exclude peripheral arterial disease","volume":"63","author":"Londero","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib134","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib135","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/iwj.12404","article-title":"The impact of foot ulceration and amputation on mortality in diabetic patients: I\u2014from ulceration to death, a systematic review","volume":"13","author":"Jupiter","year":"2016","journal-title":"Int Wound J"},{"key":"10.1016\/j.jacc.2025.09.003_bib136","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diabres.2019.05.003","article-title":"Effectiveness of a theory-based foot care education program (3STEPFUN) in improving foot self-care behaviours and foot risk factors for ulceration in people with type 2 diabetes","volume":"152","author":"Nguyen","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"Suppl 2","key":"10.1016\/j.jacc.2025.09.003_bib137","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2015.10.003","article-title":"The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine","volume":"63","author":"Hingorani","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib138","first-page":"1","article-title":"Best practice recommendations for the prevention and management of diabetic foot ulcers","author":"Botros","year":"2017","journal-title":"Foundations of Best Practice for Skin and Wound Management. Wound Care Canada"},{"key":"10.1016\/j.jacc.2025.09.003_bib139","article-title":"The effect of an intensive patients' education program on anxiety, depression and patient global assessment in diabetic foot ulcer patients with Wagner grade 1\/2: a randomized, controlled study","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacc.2025.09.003_bib140","first-page":"CD007610","article-title":"Complex interventions for preventing diabetic foot ulceration","volume":"2015","author":"Hoogeveen","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacc.2025.09.003_bib141","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1534734619900415","article-title":"Quality of life in diabetic foot ulcer: associated factors and the impact of anxiety\/depression and adherence to self-care","volume":"19","author":"Polikandrioti","year":"2020","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.jacc.2025.09.003_bib142","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2018-000638","article-title":"Visual impairment and mortality in patients with type 2 diabetes","volume":"7","author":"Siersma","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2025.09.003_bib143","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/dmrr.2760","article-title":"Innovations in plantar pressure and foot temperature measurements in diabetes","volume":"32","author":"Bus","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jacc.2025.09.003_bib144","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S2213-8587(18)30290-0","article-title":"Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial","volume":"6","author":"Bonaca","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacc.2025.09.003_bib145","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012177","article-title":"Lifetime risk of lower-extremity peripheral artery disease defined by ankle-brachial index in the United States","volume":"8","author":"Matsushita","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacc.2025.09.003_bib146","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jamasurg.2013.1436","article-title":"Influence of race on the management of lower extremity ischemia: revascularization vs amputation","volume":"148","author":"Durazzo","year":"2013","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib147","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s40615-016-0261-9","article-title":"Explaining racial disparities in amputation rates for the treatment of peripheral artery disease (PAD) using decomposition methods","volume":"4","author":"Mustapha","year":"2017","journal-title":"J Racial Ethn Health Disparities"},{"key":"10.1016\/j.jacc.2025.09.003_bib148","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jvs.2011.02.035","article-title":"Racial disparities in the use of revascularization before leg amputation in Medicare patients","volume":"54","author":"Holman","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib149","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.ahj.2009.09.014","article-title":"Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry","volume":"158","author":"Meadows","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2025.09.003_bib150","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jvs.2007.07.021","article-title":"Disparities in the treatment and outcomes of vascular disease in Hispanic patients","volume":"46","author":"Morrissey","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib151","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jacc.2019.11.057","article-title":"Sex-specific risks of major cardiovascular and limb events in patients with symptomatic peripheral artery disease","volume":"75","author":"Haine","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib152","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jvs.2013.07.114","article-title":"Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease","volume":"59","author":"Lo","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib153","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.semvascsurg.2022.05.003","article-title":"Disparities in peripheral artery disease care: a review and call for action","volume":"35","author":"Demsas","year":"2022","journal-title":"Semin Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib154","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/1358863X20981132","article-title":"Association of peripheral artery disease and chronic limb-threatening ischemia with socioeconomic deprivation in people with diabetes: a population data-linkage and geospatial analysis","volume":"26","author":"Hurst","year":"2021","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev-publhealth-031914-122755","article-title":"The double disparity facing rural local health departments","volume":"37","author":"Harris","year":"2016","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.jacc.2025.09.003_bib156","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jvs.2019.10.090","article-title":"The effect of rurality on the risk of primary amputation is amplified by race","volume":"72","author":"Minc","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib157","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2023.0479","article-title":"Association of health care utilization and access to care with vascular assessment before major lower extremity amputation among US veterans","volume":"158","author":"Alabi","year":"2023","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib158","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"387","author":"Farber","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib159","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(23)00462-2","volume":"401","author":"Bradbury","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2025.09.003_bib160","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1067\/mva.2002.129112","article-title":"Genetic interventions for vein bypass graft disease: a review","volume":"36","author":"Conte","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib161","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jvs.2005.12.058","article-title":"Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery","volume":"43","author":"Conte","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib162","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jvs.2007.08.033","article-title":"Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial","volume":"46","author":"Schanzer","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib163","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/1358863X18785026","article-title":"Associations of exercise ankle-brachial index, pain-free walking distance and maximum walking distance with the Peripheral Artery Questionnaire: finding from the PORTRAIT PAD Registry","volume":"24","author":"Hammad","year":"2019","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib164","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/ijcp.12494","article-title":"Peripheral artery questionnaire improves ankle brachial index screening in symptomatic patients with peripheral artery disease","volume":"68","author":"Kim","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jacc.2025.09.003_bib165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.114.007002","article-title":"Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease","volume":"130","author":"McDermott","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib166","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jvs.2013.08.099","article-title":"Vascular Quality of Life Questionnaire-6 facilitates health-related quality of life assessment in peripheral arterial disease","volume":"59","author":"Nordanstig","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib167","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/1358863X17747047","article-title":"Association between health status and sociodemographic, clinical and treatment disparities in the Patient-centered Outcomes Related to TReatment Practices in Peripheral Arterial Disease: Investigating Trajectories (PORTRAIT) registry","volume":"23","author":"Noyes","year":"2018","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib168","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/1358863X12466708","article-title":"The PADQOL: development and validation of a PAD-specific quality of life questionnaire","volume":"17","author":"Treat-Jacobson","year":"2012","journal-title":"Vasc Med"},{"key":"10.1016\/j.jacc.2025.09.003_bib169","doi-asserted-by":"crossref","first-page":"507","DOI":"10.5830\/CVJA-2012-019","article-title":"Neo-intimal hyperplasia, diabetes and endovascular injury","volume":"23","author":"Kruger","year":"2012","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.jacc.2025.09.003_bib170","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jvs.2013.08.019","article-title":"Vein graft failure","volume":"61","author":"Owens","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib171","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ejvs.2019.06.017","volume":"58","author":"Venermo","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib172","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jvs.2018.04.018","article-title":"The Society for Vascular Surgery practice guidelines on follow-up after vascular surgery arterial procedures","volume":"68","author":"Zierler","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib173","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jacc.2012.02.009","volume":"60","author":"Mohler","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib174","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.semvascsurg.2014.11.002","article-title":"Surveillance and follow-up after revascularization for critical limb ischemia","volume":"27","author":"Barleben","year":"2014","journal-title":"Semin Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib175","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jacr.2018.03.011","article-title":"ACR appropriateness criteria\u00ae: lower extremity arterial revascularization-post-therapy imaging","volume":"15","author":"Cooper","year":"2018","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.jacc.2025.09.003_bib176","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.avsg.2018.08.079","article-title":"Ultrasound surveillance in endovascular revascularization of lower limbs","volume":"56","author":"Martinez-Rico","year":"2019","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib177","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.jvs.2017.06.113","article-title":"Systematic review and meta-analysis of duplex ultrasound surveillance for infrainguinal vein bypass grafts","volume":"66","author":"Abu Dabrh","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib178","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/CIRCULATIONAHA.104.518738","article-title":"Is duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST)","volume":"112","author":"Davies","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2025.09.003_bib179","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jvs.2007.07.046","article-title":"The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure","volume":"46","author":"Brumberg","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib180","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0741-5214(94)90289-5","article-title":"Duplex scan surveillance of infrainguinal prosthetic bypass grafts","volume":"20","author":"Lalak","year":"1994","journal-title":"J Vasc Surg"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2025.09.003_bib181","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib182","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jvs.2014.05.101","article-title":"Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia","volume":"61","author":"Chung","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib183","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.avsg.2016.09.024","article-title":"Aggressive wound care by a multidisciplinary team improves wound healing after infrainguinal bypass in patients with critical limb ischemia","volume":"41","author":"Mii","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib184","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/dmrr.2299","article-title":"The impact and outcomes of establishing an integrated interdisciplinary surgical team to care for the diabetic foot","volume":"28","author":"Armstrong","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jacc.2025.09.003_bib185","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1526602819826593","article-title":"Multidisciplinary care for critical limb ischemia: current gaps and opportunities for improvement","volume":"26","author":"Armstrong","year":"2019","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.jacc.2025.09.003_bib186","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib187","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.jvs.2019.01.087","article-title":"Benefit of multidisciplinary wound care center on the volume and outcomes of a vascular surgery practice","volume":"70","author":"Flores","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jacc.2025.09.003_bib188","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.avsg.2014.10.030","article-title":"Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service","volume":"29","author":"Vartanian","year":"2015","journal-title":"Ann Vasc Surg"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725077186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109725077186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:56:49Z","timestamp":1787669809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109725077186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":186,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0735109725077186"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2025.09.003","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2026 ACC\/AHA Clinical Performance and Quality Measures for Patients With Peripheral Artery Disease","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2025.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation","name":"copyright","label":"Copyright"}]}}